Mlf1 Interacting Protein (phospho Thr78) antibody

GeneTex

Mlf1 Interacting Protein (phospho Thr78) antibody

9

WB: 1:500-1:2000. IHC-P: 20 microg/mL. ELISA: 1:5000-1:25000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

CENPU

centromere protein U

CENP50; CENPU50; centromere protein of 50 kDa; centromere protein U; interphase centromere complex protein 24; KLIP1; KSHV latent nuclear antigen interacting protein 1; MLF1 interacting protein; MLF1IP; PBIP1; polo-box-interacting protein 1

Rabbit

IgG

Centromere protein U

Myeloid leukemia factor-1 (MLF1) Interacting Protein (also known as PBIP1, MLF1IP1, KLIP1 or KSHV latent nuclear antigen interacting protein 1) is a novel polo-like kinase 1 (Plk1) substrate. Plk1 phosphorylation of MLF1IP induces ubiquitination and degradation of MLF1IP prior to the metaphase/ anaphase transition. Several Plk1-dependent phosphorylation sites have been identified on MLF1IP by mass spectrometry. Mutations of these sites stabilize MLF1IP and inhibit mitotic progression. Subsequent in vitro and in vivo MLF1IP phosphorylation and stability assays have revealed that phosphorylation of Thr78 is critical for triggering Plk1-dependent MLF1IP degradation. Expression of a non-degradable Thr78Ala mutant was sufficient to induce a mitotic block. Timely phosphorylation of MLF1IP on Thr78 by Plk1 is critical for eliminating the MLF1IP-imposed mitotic block prior to anaphase onset. MLF1IP is speculated to be a novel tumor suppressor.

-20°C or -80°C,2°C to 8°C

12352203